MD374C2 - The method of obtaining tablets - Google Patents

The method of obtaining tablets

Info

Publication number
MD374C2
MD374C2 MD95-0073A MD950073A MD374C2 MD 374 C2 MD374 C2 MD 374C2 MD 950073 A MD950073 A MD 950073A MD 374 C2 MD374 C2 MD 374C2
Authority
MD
Moldova
Prior art keywords
tablets
obtaining
obtaining tablets
vinylpivrolidone
pirrolidone
Prior art date
Application number
MD95-0073A
Other languages
Romanian (ro)
Russian (ru)
Inventor
Goertz Hans-Helmut
Guenther Klimesch Roger
Laemmerhirt Klaus
Lang Siegfried
Sanner Axel
Spengler Reinhard
Original Assignee
Basf Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Aktiengesellschaft filed Critical Basf Aktiengesellschaft
Publication of MD374C2 publication Critical patent/MD374C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2105/00—Condition, form or state of moulded material or of the material to be shaped
    • B29K2105/0005—Condition, form or state of moulded material or of the material to be shaped containing compounding ingredients
    • B29K2105/0035—Medical or pharmaceutical agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Surgical Instruments (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)

Abstract

The invention relates to the chemical - pharmaceutical industry and concerns the process for tablets obtaining.The purpose - consists in the simplification of the process. The N - vinyl-pirrolidone and vinylacetate copolymer with the N - vinylpivrolidone content of 30-100 mass % is mixed with an active substance under certain temperature and are formed the tablets.
MD95-0073A 1986-04-11 1994-12-29 The method of obtaining tablets MD374C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863612212 DE3612212A1 (en) 1986-04-11 1986-04-11 METHOD FOR PRODUCING SOLID PHARMACEUTICAL FORMS

Publications (1)

Publication Number Publication Date
MD374C2 true MD374C2 (en) 1996-05-31

Family

ID=6298473

Family Applications (1)

Application Number Title Priority Date Filing Date
MD95-0073A MD374C2 (en) 1986-04-11 1994-12-29 The method of obtaining tablets

Country Status (20)

Country Link
US (1) US4801460A (en)
EP (1) EP0240904B1 (en)
JP (1) JPH089551B2 (en)
KR (1) KR920003575B1 (en)
CN (1) CN1022666C (en)
AT (1) ATE77739T1 (en)
AU (1) AU587897B2 (en)
CA (1) CA1308353C (en)
CS (1) CS268177B2 (en)
DE (2) DE3612212A1 (en)
ES (1) ES2037020T3 (en)
FI (1) FI87887C (en)
GR (1) GR3005866T3 (en)
HU (1) HU196132B (en)
MD (1) MD374C2 (en)
NO (1) NO170570C (en)
PT (1) PT84661B (en)
SU (1) SU1731037A3 (en)
UA (1) UA13038A1 (en)
YU (1) YU46534B (en)

Families Citing this family (157)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3612211A1 (en) * 1986-04-11 1987-10-15 Basf Ag CONTINUOUS TABLET METHOD
US5051261A (en) * 1987-11-24 1991-09-24 Fmc Corporation Method for preparing a solid sustained release form of a functionally active composition
CA1334379C (en) * 1987-11-24 1995-02-14 James William Mcginity Method for preparing a solid sustained release form of a functionally active composition
DE3803482A1 (en) * 1988-02-05 1989-08-17 Lohmann Therapie Syst Lts FLOATING ORAL THERAPEUTIC SYSTEM
DE3807895A1 (en) * 1988-03-10 1989-09-21 Knoll Ag PRODUCTS CONTAINING A CALCIUM ANTAGONIST AND A LIPID DOWNER
DE3812567A1 (en) * 1988-04-15 1989-10-26 Basf Ag METHOD FOR PRODUCING PHARMACEUTICAL MIXTURES
DE3830353A1 (en) * 1988-09-07 1990-03-15 Basf Ag METHOD FOR THE CONTINUOUS PRODUCTION OF SOLID PHARMACEUTICAL FORMS
DE3830355A1 (en) * 1988-09-07 1990-03-15 Basf Ag METHOD FOR PRODUCING PHARMACEUTICAL TABLETS
PH26730A (en) * 1988-12-30 1992-09-28 Ciba Geigy Ag Coated adhesive tablets
US5310549A (en) * 1989-08-31 1994-05-10 Ecolab Inc. Solid concentrate iodine composition
WO1991007184A1 (en) * 1989-11-08 1991-05-30 Gaf Chemicals Corporation SUBSTANTIALLY ANHYDROUS COMPLEXES OF PVP and H2O¿2?
US5008106A (en) * 1989-12-14 1991-04-16 Gaf Chemicals Corporation Method for reducing the microbial content of surfaces with a microbiocidal, anhydrous complex of PVP-H2 O2
IE63986B1 (en) * 1989-12-30 1995-06-28 Akzo Nv Pharmaceutical preparation for oral administration in fluid form
FR2663818B1 (en) † 1990-06-29 1993-07-09 Rhone Poulenc Nutrition Animale PROCESS FOR THE PREPARATION OF GRANULES OF ACTIVE PRINCIPLES BY EXTRUSION.
DE4031881C2 (en) * 1990-10-08 1994-02-24 Sanol Arznei Schwarz Gmbh Solvent-free, oral sustained-release pharmaceutical preparation and process for its preparation
ATE144424T1 (en) * 1991-04-09 1996-11-15 Takeda Chemical Industries Ltd STABILIZED VITAMIN D MEDICINAL PRODUCT
EP0580860B2 (en) * 1991-04-16 2004-12-15 Nippon Shinyaku Company, Limited Method of manufacturing solid dispersion
US5286497A (en) * 1991-05-20 1994-02-15 Carderm Capital L.P. Diltiazem formulation
US5326570A (en) * 1991-07-23 1994-07-05 Pharmavene, Inc. Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
DE122004000032I2 (en) 1991-09-06 2006-02-09 Mcneilab Inc Composition containing a tramadol compound and acetaminophen, and their use
WO1993007859A1 (en) * 1991-10-23 1993-04-29 Warner-Lambert Company Novel pharmaceutical pellets and process for their production
DE4138513A1 (en) * 1991-11-23 1993-05-27 Basf Ag SOLID PHARMACEUTICAL RETARD FORM
WO1993011749A1 (en) 1991-12-18 1993-06-24 Warner-Lambert Company A process for the preparation of a solid dispersion
US5190749A (en) * 1992-01-13 1993-03-02 Isp Investments Inc. Copolymers of vinyl pyrrolidone and a quaternary ammonium monomer complexed with H2 O2 in the form of free-flowing powders
US5429825A (en) * 1992-06-26 1995-07-04 Mcneil-Ppc, Inc. Rotomelt granulation
TW246635B (en) * 1992-10-08 1995-05-01 Shell Internat Res Schappej B V
NZ260408A (en) 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
DE4316537A1 (en) * 1993-05-18 1994-11-24 Basf Ag Preparations in the form of solid solutions
EP0729748B1 (en) * 1993-11-18 2003-02-26 Nippon Shinyaku Company, Limited Process for producing stable medicinal composition
KR100354702B1 (en) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 Manufacturing method and sustained release composition of pharmaceutical composition
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
DE4413350A1 (en) 1994-04-18 1995-10-19 Basf Ag Retard matrix pellets and process for their production
EP0691124A1 (en) * 1994-07-07 1996-01-10 Sara Lee/DE N.V. Mouth care products
GB9422154D0 (en) * 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US20020006438A1 (en) * 1998-09-25 2002-01-17 Benjamin Oshlack Sustained release hydromorphone formulations exhibiting bimodal characteristics
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
US5871776A (en) * 1995-01-31 1999-02-16 Mehta; Atul M. Controlled-release nifedipine
DE19504832A1 (en) * 1995-02-14 1996-08-22 Basf Ag Solid drug preparations
DE19509805A1 (en) * 1995-03-21 1996-09-26 Basf Ag Transparent, fast-release formulations of nonsteroidal analgesics
DE19509806A1 (en) * 1995-03-21 1996-09-26 Basf Ag Storage stable dosage forms
DE19511131A1 (en) * 1995-03-27 1996-10-02 Basf Ag Mechanically stable solid active substance preparation forms
US5900425A (en) * 1995-05-02 1999-05-04 Bayer Aktiengesellschaft Pharmaceutical preparations having controlled release of active compound and processes for their preparation
BE1009375A6 (en) * 1995-05-29 1997-02-04 Picanol Nv Edge device for looms.
US5869079A (en) * 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
US20060280774A1 (en) * 1995-06-02 2006-12-14 Allergan, Inc. Compositions and methods for treating glaucoma
WO1997008950A1 (en) * 1995-09-07 1997-03-13 Fuisz Technologies, Ltd. System for rendering substantially non-dissoluble bio-affecting agents bio-available
DE19539361A1 (en) * 1995-10-23 1997-04-24 Basf Ag Process for the preparation of multilayer, solid pharmaceutical forms for oral or rectal administration
DE19602206A1 (en) 1996-01-23 1997-07-24 Basf Ag Preparations of nonsteroidal analgesics
US6090419A (en) * 1996-05-02 2000-07-18 Mccormick & Company, Inc. Salt compositions and method of preparation
DE19629040A1 (en) * 1996-07-19 1998-01-22 Basf Ag Pharmaceutical forms containing plant extract
DE19629753A1 (en) 1996-07-23 1998-01-29 Basf Ag Process for the production of solid dosage forms
DE19635676A1 (en) * 1996-09-03 1998-03-05 Basf Ag Solid foamed active ingredient preparations
TW474824B (en) 1996-09-13 2002-02-01 Basf Ag The production of solid pharmaceutical forms
DE19649565A1 (en) * 1996-11-29 1998-06-04 Knoll Ag Process for producing granules of a detergent or cleaning agent
DE19710213A1 (en) * 1997-03-12 1998-09-17 Basf Ag Process for the manufacture of solid combination dosage forms
DE19753298A1 (en) * 1997-12-01 1999-06-02 Basf Ag Process for the preparation of solid dosage forms
DE19812688A1 (en) 1998-03-23 1999-09-30 Basf Ag Solid dosage forms useful for slow release of drugs, fragrances, plant-treating agents, animal feed additives and food additives
DE19814730A1 (en) * 1998-04-02 1999-10-07 Basf Ag Pharmaceutical and cosmetic compositions with matrix containing N-vinyllactam or N-vinylamine based copolymer
ID26401A (en) 1998-04-30 2000-12-21 Basf Ag SLOW DISPOSAL FORMULATION FROM HARVEST RESULTS
US6197347B1 (en) 1998-06-29 2001-03-06 Andrx Pharmaceuticals, Inc. Oral dosage for the controlled release of analgesic
DE19840256A1 (en) 1998-09-03 2000-03-09 Basf Ag Widely applicable, continuous method for preparing coated solid dosage forms, comprises extruding mixture of drug and thermoplastic binder then applying coating composition in liquid or vapor form
DE19841244A1 (en) 1998-09-09 2000-03-16 Knoll Ag Method and device for making tablets
DE19842753A1 (en) 1998-09-18 2000-03-23 Bayer Ag Multiple-unit retard oral dosage formulation having controlled release independent of agitation and food effect, containing particles of combination of drug and hydroxypropyl cellulose
DE19842914A1 (en) 1998-09-18 2000-03-23 Basf Ag Test system to characterize the compatibility of biologically active substances and polyvinylpyrrolidone
DE19843903A1 (en) * 1998-09-24 2000-03-30 Basf Ag Solid dosage form for prolonged slow release of e.g. drugs, plant treatment agents or food or feed additives, containing copolymer of N-vinyl-lactam and methyl methacrylate as binder
DE19843904A1 (en) * 1998-09-24 2000-03-30 Basf Ag Solid dosage form for prolonged slow release of e.g. drugs, plant treatment agents, or food or feed additives, containing copolymer of N-vinyl-lactam, methyl methacrylate and further monomer(s) as binder
DE19847618A1 (en) 1998-10-15 2000-04-20 Basf Ag Production of solid dosage forms, used for e.g. pharmaceuticals or insecticides, by preparation of plastic mixture from polymeric binder and active agent under controlled conditions
AU1160500A (en) * 1998-11-12 2000-06-05 Basf Aktiengesellschaft Plant protection agents in tablet form
DE19853985A1 (en) * 1998-11-23 2000-05-25 Basf Ag Producing solid dosage form, using molding calender of two cylinders with specific surface structures, avoids problems of misalignment of upper and lower halves of the product
US6455526B1 (en) 1998-12-16 2002-09-24 Aventis Pharmaceuticals, Inc. Biodegradable polymer encapsulated pharmaceutical compositions and method for preparing the same
IL143761A0 (en) * 1998-12-16 2002-04-21 Aventis Pharma Inc Biodegradable polymer encapsulated serotonin receptor antagonist and method for preparing the same
DE19901383A1 (en) 1999-01-15 2000-07-20 Knoll Ag Process for the preparation of different solid dosage forms
DE19913692A1 (en) 1999-03-25 2000-09-28 Basf Ag Mechanically stable pharmaceutical dosage forms containing liquid or semi-solid surface-active substances
DE19918325A1 (en) 1999-04-22 2000-10-26 Euro Celtique Sa Extruded drug dosage form, e.g. granulate for tableting, comprising an active agent in a polysaccharide-containing matrix, giving a release profile which is controllable by extrusion conditions and/or the inclusion of additives
DE19934610A1 (en) * 1999-07-23 2001-01-25 Bayer Ag Rapid-release extrudates containing low viscosity hydroxypropylcellulose, useful for formulating plant protecting agents and oral pharmaceutical and veterinary compositions
DE19943501A1 (en) * 1999-09-10 2001-03-15 Basf Ag Underwater granulation of melts containing active ingredients
DE19945982A1 (en) * 1999-09-24 2001-03-29 Knoll Ag Velocity-determined particles
US6331313B1 (en) 1999-10-22 2001-12-18 Oculex Pharmaceticals, Inc. Controlled-release biocompatible ocular drug delivery implant devices and methods
EP1175205B1 (en) * 1999-11-12 2006-06-14 Abbott Laboratories Solid dispersion comprising ritonavir, fenofibrate or griseofulvin
US7364752B1 (en) 1999-11-12 2008-04-29 Abbott Laboratories Solid dispersion pharamaceutical formulations
US6544553B1 (en) * 1999-12-28 2003-04-08 Watson Pharmaceuticals, Inc. Dosage forms and methods for oral delivery of progesterone
DE10017102A1 (en) 2000-04-06 2001-10-11 Basf Ag Process for the manufacture of solid creatine dosage forms and dosage forms obtainable thereby
US6635277B2 (en) 2000-04-12 2003-10-21 Wockhardt Limited Composition for pulsatile delivery of diltiazem and process of manufacture
DE10026698A1 (en) 2000-05-30 2001-12-06 Basf Ag Self-emulsifying active ingredient formulation and use of this formulation
DE10029201A1 (en) * 2000-06-19 2001-12-20 Basf Ag Retarded release oral dosage form, obtained by granulating mixture containing active agent and polyvinyl acetate-polyvinyl pyrrolidone mixture below the melting temperature
US6726918B1 (en) 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye
US6500457B1 (en) 2000-08-14 2002-12-31 Peirce Management, Llc Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent
DE10046541A1 (en) * 2000-09-19 2002-03-28 Knoll Ag Oral dosage form useful as nutritional supplement or medicament comprises solid dispersion of ubiquinone in thermoplastic matrix
WO2002043785A2 (en) 2000-11-29 2002-06-06 Oculex Pharmaceuticals, Inc. Intraocular implants for preventing transplant rejection in the eye
US7883721B2 (en) 2001-01-30 2011-02-08 Smithkline Beecham Limited Pharmaceutical formulation
US7842308B2 (en) * 2001-01-30 2010-11-30 Smithkline Beecham Limited Pharmaceutical formulation
US20050175687A1 (en) * 2001-01-30 2005-08-11 Mcallister Stephen M. Pharmaceutical formulations
GB0102342D0 (en) 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
GB0113841D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
WO2003057197A1 (en) * 2002-01-03 2003-07-17 Smithkline Beecham Corporation Novel pharmaceutical dosage forms and method for producing same
AR038375A1 (en) 2002-02-01 2005-01-12 Pfizer Prod Inc PHARMACEUTICAL COMPOSITIONS OF INHIBITORS OF THE PROTEIN OF TRANSFER OF ESTERES DE COLESTERILO
JP2005522424A (en) 2002-02-01 2005-07-28 ファイザー・プロダクツ・インク Controlled release drug dosage forms of cholesteryl ester transfer protein inhibitors
US8128957B1 (en) * 2002-02-21 2012-03-06 Valeant International (Barbados) Srl Modified release compositions of at least one form of tramadol
US20050182056A9 (en) * 2002-02-21 2005-08-18 Seth Pawan Modified release formulations of at least one form of tramadol
BR0308482A (en) * 2002-03-11 2005-02-22 Alcon Inc Implantable drug delivery system
DE10213242A1 (en) * 2002-03-25 2003-10-16 Abbott Gmbh & Co Kg Test system for evaluating the compatibility of biologically active substances with copolymers
AU2003249474A1 (en) 2002-08-12 2004-02-25 Pfizer Products Inc. Pharmaceutical compositions of semi-ordered drugs and polymers
WO2004026256A2 (en) * 2002-09-20 2004-04-01 Alpharma, Inc. Sustained-release opioid formulations and methods of use
DE10247037A1 (en) * 2002-10-09 2004-04-22 Abbott Gmbh & Co. Kg Solid, rapid release dosage form, especially for sparingly soluble drugs, obtained by forming and cooling softened, shapable mixture of crosslinked non-thermoplastic carrier, adjuvant and active agent
EP1572190B1 (en) * 2002-12-17 2007-04-18 Abbott GmbH & Co. KG Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof
US20080051411A1 (en) * 2002-12-17 2008-02-28 Cink Russell D Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof
US20050048099A1 (en) 2003-01-09 2005-03-03 Allergan, Inc. Ocular implant made by a double extrusion process
US7423004B2 (en) * 2003-01-31 2008-09-09 Smithkline Beecham Corporation Solid dispersion compositions
WO2004069138A2 (en) * 2003-02-03 2004-08-19 Novartis Ag Pharmaceutical formulation
US20050100608A1 (en) * 2003-02-21 2005-05-12 Watson Pharmaceuticals, Inc. Testosterone oral dosage formulations and associated methods
US20040219210A1 (en) * 2003-05-01 2004-11-04 Jian-Hwa Guo Controlled release solid dosage nifedipine formulations
US7250475B2 (en) * 2003-06-26 2007-07-31 Symyx Technologies, Inc. Synthesis of photoresist polymers
TW200526274A (en) 2003-07-21 2005-08-16 Smithkline Beecham Plc Pharmaceutical formulations
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
WO2005027864A1 (en) * 2003-09-19 2005-03-31 Symyx Technologies, Inc. Materials for enhanced delivery of hydrophilic active agents in personal care formulations
EP1686965A2 (en) * 2003-11-18 2006-08-09 Boehringer Ingelheim International GmbH Solid pharmaceutical preparation form
GB0403098D0 (en) * 2004-02-12 2004-03-17 Euro Celtique Sa Extrusion
TWI350762B (en) * 2004-02-12 2011-10-21 Euro Celtique Sa Particulates
PE20060003A1 (en) * 2004-03-12 2006-03-01 Smithkline Beecham Plc POLYMERIC PHARMACEUTICAL FORMULATION FOR INJECTION MOLDING
US20050244469A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Extended therapeutic effect ocular implant treatments
EP1750669A1 (en) * 2004-05-04 2007-02-14 Boehringer Ingelheim International Gmbh Solid pharmaceutical form comprising an ltb4 antagonist
ES2452733T3 (en) 2004-05-28 2014-04-02 Abbvie Deutschland Gmbh & Co Kg Dosage form obtainable from a powdery mixture comprising an inorganic pigment
FR2875409B1 (en) * 2004-09-17 2010-05-07 Sanofi Aventis PHARMACEUTICAL COMPOSITION COMPRISING A SOLID POLYMERIC MATRIX DISPERSION COMPRISING A CONTINUOUS PHASE OF POLYDEXTROSE AND A CONTINUOUS PHASE OF A POLYMER OTHER THAN POLYDEXTROSE
BRPI0609910A2 (en) * 2005-05-10 2010-05-11 Novartis Ag modified release famciclovir pharmaceutical compositions
US7884136B2 (en) 2005-06-27 2011-02-08 Biovail Laboratories International S.R.L. Modified-release formulations of a bupropion salt
WO2007003278A1 (en) * 2005-07-05 2007-01-11 Abbott-Gmbh & Co. Kg Composition and dosage form comprising a solid or semi-solid matrix
PT1912626T (en) 2005-08-08 2016-07-20 Abbvie Deutschland Dosage forms with improved bioavailability
US8486456B2 (en) 2005-08-08 2013-07-16 Abbott Gmbh & Co., Kg Itraconazole compositions with improved bioavailability
US7534381B2 (en) * 2005-09-14 2009-05-19 Isp Investments Inc. Process and apparatus for forming agglomerates of a powder composition of an active and binder
US20070178138A1 (en) * 2006-02-01 2007-08-02 Allergan, Inc. Biodegradable non-opthalmic implants and related methods
EP1832281A1 (en) 2006-03-10 2007-09-12 Abbott GmbH & Co. KG Process for producing a solid dispersion of an active ingredient
US8802128B2 (en) * 2006-06-23 2014-08-12 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US20070298073A1 (en) * 2006-06-23 2007-12-27 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US20080057122A1 (en) * 2006-08-31 2008-03-06 Aaipharma Inc. Acetaminophen pharmaceutical compositions
EP2112925A4 (en) * 2006-11-15 2013-01-09 Abbott Lab Solid pharmaceutical dosage formulations
US20080145405A1 (en) * 2006-12-15 2008-06-19 Kunzler Jay F Drug delivery devices
RU2356539C2 (en) * 2006-12-28 2009-05-27 Закрытое Акционерное Общество "Канонфарма Продакшн" Solid formulation betahistine dihydrochloride and related production procedure
US7607596B1 (en) 2007-03-07 2009-10-27 Exxpharma, LLC Process for enhancing the solubility of poorly soluble drugs
EP2219624A2 (en) 2007-11-08 2010-08-25 Glaxo Group Limited Pharmaceutical formulations
US20090246276A1 (en) 2008-01-28 2009-10-01 Graham Jackson Pharmaceutical Compositions
CA2727630A1 (en) * 2008-06-13 2009-12-17 Glaxo Group Limited Pharmaceutical formulations
US20100003322A1 (en) * 2008-07-03 2010-01-07 Lai Felix S Enteric coated hydrophobic matrix formulation
WO2010040686A1 (en) * 2008-10-07 2010-04-15 Basf Se Method for producing controlled-release oral dosage forms
ES2598178T5 (en) * 2008-10-07 2023-12-26 Kudos Pharm Ltd Pharmaceutical formulation 514
CN102573755A (en) * 2009-09-18 2012-07-11 巴斯夫欧洲公司 Method for producing preparations of substances with low solubility in water
WO2011101352A2 (en) 2010-02-18 2011-08-25 Abbott Gmbh & Co. Kg Test solvent for evaluating the compatibility of biologically active substances and graft copolymers
EP2463327A3 (en) 2010-12-10 2015-06-03 Basf Se Method for producing granulates containing at least one water-soluble component
CN103260609B (en) 2010-12-23 2017-08-11 雅培股份有限两合公司 Solid based on solid dispersions delays preparation
HK1232218A1 (en) 2014-02-05 2018-01-05 Merck Sharp & Dohme Llc Tablet formulation for cgrp-active compounds
CN104666084B (en) * 2014-11-27 2018-07-13 天津坤健生物制药有限公司 A method of it improves and delays controlled release coat piece dissolution rate stability
MD4399C1 (en) * 2015-02-19 2016-09-30 Государственный Университет Молд0 Polymeric material with antibacterial properties
CN107920998B (en) * 2015-08-21 2021-07-27 巴斯夫欧洲公司 Use of water-soluble polymers based on N-vinylpyrrolidone and acrylic acid as pharmaceutical adjuvants
WO2017032651A1 (en) * 2015-08-21 2017-03-02 Basf Se Salts of active ingredients with polymeric counterions
WO2018064181A1 (en) 2016-09-27 2018-04-05 Porter Kenneth L Harvested bale wrapping material sheets
AU2018360383A1 (en) 2017-11-02 2020-05-21 Natureceuticals Sdn. Bhd. Extract of orthosiphon stamineus, formulations, and uses thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1348786A (en) * 1971-05-14 1974-03-20 Plessey Co Ltd Apparatus and methods for assessing the length of a moving vehicle

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3089818A (en) * 1960-06-02 1963-05-14 Baxter Laboratories Inc Water dispersible antibiotics
DE1137009B (en) * 1961-01-04 1962-09-27 Bayer Ag Process for the preparation of an easily soluble streptomycin salt
NL297357A (en) * 1962-08-31
GB1388786A (en) * 1972-04-03 1975-03-26 Scherer Corp R P Integral solid gel-lattice dosage form of high-moisture content
CA1211892A (en) * 1982-09-20 1986-09-23 James R. Cho Preparation of polyvinylpyrrolidone or vinylpyrrolidone/vinyl acetate copolymers of various molecular weights using a single initiator system
DD220225A5 (en) * 1983-03-16 1985-03-27 Boehringer Ingelheim Ltd PROCESS FOR PREPARING A SOLID-BODY DISPERSION OF CHLORO-THALIDONE
DE3312668A1 (en) * 1983-04-08 1984-10-11 Basf Ag, 6700 Ludwigshafen WATER-SOLUBLE POLYMERS WITH LOW HYGROSCOPY
US4661521A (en) * 1984-04-30 1987-04-28 Mallinckrodt, Inc. Direct tableting acetaminophen compositions
US4631284A (en) * 1984-11-19 1986-12-23 Mallinckrodt, Inc. Acetaminophen compositions containing low doses of chlorpheniramine maleate, method for preparing same and tablets formed therefrom
FR2581541B1 (en) * 1985-05-09 1988-05-20 Rhone Poulenc Sante NOVEL PHARMACEUTICAL COMPOSITIONS FOR THE EXTENDED RELEASE OF AN ACTIVE INGREDIENT AND THEIR PREPARATION METHOD
EP0214092A1 (en) * 1985-08-08 1987-03-11 Ciba-Geigy Ag Enhanced absorption of psychoactive 2-aryl-pyrazolo quinolines as a solid molecular dispersion in polyvinylpyrrolidone

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1348786A (en) * 1971-05-14 1974-03-20 Plessey Co Ltd Apparatus and methods for assessing the length of a moving vehicle

Also Published As

Publication number Publication date
NO170570B (en) 1992-07-27
FI87887B (en) 1992-11-30
PT84661A (en) 1987-05-01
YU46534B (en) 1993-11-16
FI87887C (en) 1993-03-10
US4801460A (en) 1989-01-31
HU196132B (en) 1988-10-28
NO871513D0 (en) 1987-04-10
CN1022666C (en) 1993-11-10
HUT43958A (en) 1988-01-28
FI871539L (en) 1987-10-12
KR920003575B1 (en) 1992-05-04
EP0240904A2 (en) 1987-10-14
ATE77739T1 (en) 1992-07-15
JPH089551B2 (en) 1996-01-31
NO871513L (en) 1987-10-12
GR3005866T3 (en) 1993-06-07
AU7141387A (en) 1987-10-15
PT84661B (en) 1989-11-30
ES2037020T3 (en) 1993-06-16
AU587897B2 (en) 1989-08-31
UA13038A1 (en) 1997-02-28
DE3612212A1 (en) 1987-10-15
KR870009715A (en) 1987-11-30
SU1731037A3 (en) 1992-04-30
CN87103409A (en) 1987-12-09
YU59187A (en) 1988-08-31
EP0240904A3 (en) 1988-11-30
CS253287A2 (en) 1989-04-14
CS268177B2 (en) 1990-03-14
EP0240904B1 (en) 1992-07-01
JPS62242630A (en) 1987-10-23
CA1308353C (en) 1992-10-06
NO170570C (en) 1992-11-04
DE3780059D1 (en) 1992-08-06
FI871539A0 (en) 1987-04-08

Similar Documents

Publication Publication Date Title
MD374C2 (en) The method of obtaining tablets
FR2342984A1 (en) PROCESS FOR PREPARATION OF MIXED AROMATIC-ALIPHATIC PHOSPHITES AND NEW PRODUCTS THUS OBTAINED
ES530898A0 (en) A COMPOSITION TO DETECT THE PRESENCE OF A PEROXIDATIVELY ACTIVE SUBSTANCE IN A SAMPLE TO BE TESTED
EP0121192A3 (en) Analytical test composition, device, method for its preparation and method for the determination of peroxidatively active substance
DE3067483D1 (en) Test composition for peroxidatively active substances, test device containing the composition, process for preparing same and method for the determination of peroxidatively active substances
SE429065B (en) ELECTROCHEMICAL META SENSOR FOR DETERMINATION OF THE ACID CONTENT IN EXHAUST
ES392664A1 (en) Method of measuring serum thyroxine
ES542430A0 (en) A PROCEDURE FOR THE PREPARATION OF AN ANTICID COMPOSITION OF MAGNESIUM ALGINATE.
TR23485A (en) PROCESS TO ACCREASE THE DECREASE OF THE FERMENTATION LEVELS OF THE COMPUTER AND NATURAL UERUENES FOR THE ACTIVATION OF FERMENTATION PROCESSES
JPS5239616A (en) Soft 44th sarface active reagent and method of its use
FR2543156B1 (en) PROCESS FOR MAKING SOLID PHOTOACTIVATOR PREPARATIONS FOR USE IN THE BLEACHING OF TEXTILES AND PREPARATIONS THUS OBTAINED
BE881440A (en) PROCESS FOR THE PREPARATION OF FUEL BRIQUETTES AND PRODUCTS THUS OBTAINED
UA11075A (en) METHOD OF OBTAINING LYOPHYLISATE
BR8004856A (en) STABLE COMPOSITION IN THE ABSENCE OF OXYGEN AND PROCESS FOR ITS PREPARATION
IT8520059A0 (en) PROCEDURE AND SYSTEM FOR THE REDUCTION OF THE HARMFUL SUBSTANCE CONTENT OF COMBUSTED GAS.
MX166109B (en) PREPARATION OF N-SUBSTITUTED PIPERACINONES
FR2519021B1 (en) PROCESS FOR STABILIZING SERRAPEPTASE, COMPOSITION CONTAINING SAID STABILIZED SERRAPEPTASE AND PREPARATION THEREOF
SE8300284D0 (en) PROCEDURES AND PROCEDURES TO GET SUGAR SOLUTION
PL199855A1 (en) METHOD OF REDUCING THE CONTENT OF FATTY AND NUCLEIC ACID IN MICROBIOLOGICAL CELL MASSES
EP0031527A3 (en) Enzymatically obtained oligomer of l-amino acid, process for its preparation and uses
GB2213355B (en) Method of determining quantitative content of admixtures in alloys
FR1196685A (en) Articles of graphite, in particular for the preparation of pure substances and processes relating thereto
IT8048020A0 (en) PROCEDURE FOR THE PREPARATION OF PRACTICALLY ODORLESS REFRACTORY MASSES, STORAGE STABLE AND READY FOR PROCESSING TO BE USED IN NON-COMBUSTIBLE MASTIC AND PRESSINGS
DE58908696D1 (en) Device for determining the alcohol content and / or the calorific value of fuels.
Cobbold et al. Measurements of the free calcium concentration of single quiescent human fibroblasts before and after serum addition